Key facts
- It has raised $6.5M across 2 recorded rounds; the latest was Seed Round ($2.9M) in Sep 2022.
- Notable investors include Google for Startups, Start Path, Morgan Stanley, Morgan Stanley Inclusive Ventures Lab, TiE Atlanta Angels — 8 tracked in total.
- MedTrans Go has filed 3 Form Ds with the SEC since 2021, most recently Jan 2024 ($2.9M sold to 20 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for MedTrans Go
Funding rounds
2 roundsAbout MedTrans Go
Developer of a B2B healthcare appointment optimization platform designed to solve the problems of medical appointment cancellations in the US. The company's tech-enabled portal provides healthcare facilities access to a customizable suite of services to address the root causes of their appointment cancellations in one integrated digital platform, enabling medical practices, hospitals and facilities with services in medical transportation, interpretation, home health care, delivery and more for their patients.
- Sector
- Healthcare
- HQ
- Atlanta, GA, United States
- Founded
- 2017
- Employees
- 31
- Website
- medtransgo.com/
- Ownership
- Privately Held (backing)
MedTrans Go doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MedTrans Go shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MedTrans Go in its N-PORT filings yet. We sweep new filings monthly.